NCT01122602

Evaluate Analgesic Efficacy of Fast Release Aspirin

A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Trial Assessing the Analgesic Efficacy of a Single, Oral Dose of a Fast Release Aspirin 650 mg in Postsurgical Dental Pain

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 500 (actual)
• Sponsor: Bayer · Industry
• Sex: All
• Age: 16 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The objective of the study is to evaluate the analgesic efficacy of a single, oral dose of fast release aspirin tablets, 650 mg (2 x 325 mg) compared to regular aspirin tablets, 650 mg (2 x 325 mg) and placebo in subjects with postsurgical dental pain.

Conditions

• Drugs, Investigational

Interventions

Type	Name	Description
DRUG	Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036)	Single dose of fast acting aspirin 2 x 325 mg = 650 mg total
DRUG	Acetylsalicyclic acid (Aspirin, BAYE4465)	Single dose of regular aspirin 2 x 325 mg = 650 mg total
DRUG	Placebo	Two placebo tablets

Timeline

• Start date: 2010-04-29
• Primary completion: 2010-07-29
• Completion: 2010-08-06
• First posted: 2010-05-13
• Last updated: 2018-12-19

Locations

2 sites across 1 country: United States